Bal Pharma Limited (BALPHARMA.BO)

INR 120.0

(-0.87%)

Total Liabilities Summary of Bal Pharma Limited

  • Bal Pharma Limited's latest annual total liabilities in 2023 was 2.51 Billion INR , up 0.66% from previous year.
  • Bal Pharma Limited's latest quarterly total liabilities in 2023 FY was 2.51 Billion INR , up 0.66% from previous quarter.
  • Bal Pharma Limited reported annual total liabilities of 2.49 Billion INR in 2022, up 23.48% from previous year.
  • Bal Pharma Limited reported annual total liabilities of 2.02 Billion INR in 2021, up 8.2% from previous year.
  • Bal Pharma Limited reported quarterly total liabilities of - INR for 2023 Q1, down -100.0% from previous quarter.
  • Bal Pharma Limited reported quarterly total liabilities of - INR for 2023 Q3, down -100.0% from previous quarter.

Annual Total Liabilities Chart of Bal Pharma Limited (2023 - 2007)

Historical Annual Total Liabilities of Bal Pharma Limited (2023 - 2007)

Year Total Liabilities Total Liabilities Growth
2023 2.51 Billion INR 0.66%
2022 2.49 Billion INR 23.48%
2021 2.02 Billion INR 8.2%
2020 1.86 Billion INR -3.28%
2019 1.93 Billion INR -3.99%
2018 2.01 Billion INR 0.56%
2017 1.99 Billion INR 15.42%
2016 1.73 Billion INR 9.55%
2015 1.58 Billion INR 45.51%
2014 1.08 Billion INR 3.82%
2013 1.04 Billion INR -0.5%
2012 1.05 Billion INR 4.07%
2011 1.01 Billion INR 2.22%
2010 989.1 Million INR 11.84%
2009 884.39 Million INR 4.75%
2008 844.29 Million INR 14.39%
2007 738.08 Million INR 0.0%

Peer Total Liabilities Comparison of Bal Pharma Limited

Name Total Liabilities Total Liabilities Difference
Ajanta Pharma Limited 10.71 Billion INR 76.553%
Amrutanjan Health Care Limited 783.82 Million INR -220.388%
Sigachi Industries Limited 2.53 Billion INR 0.79%
Ind-Swift Laboratories Limited 2.28 Billion INR -9.689%
Medico Remedies Limited 438.24 Million INR -473.031%
Lasa Supergenerics Limited 541.92 Million INR -363.399%
Venus Remedies Limited 1.39 Billion INR -80.304%
Sun Pharma Advanced Research Company Limited 3.89 Billion INR 35.491%
Alpa Laboratories Limited 307.12 Million INR -717.68%
Nectar Lifesciences Limited 11.21 Billion INR 77.614%
Shilpa Medicare Limited 12.93 Billion INR 80.582%
Aarti Drugs Limited 11.5 Billion INR 78.17%
Lupin Limited 96.23 Billion INR 97.391%
Aurobindo Pharma Limited 152.2 Billion INR 98.35%
Zydus Lifesciences Limited 71.79 Billion INR 96.502%
Windlas Biotech Limited 1.76 Billion INR -42.468%
Suven Life Sciences Limited 148.62 Million INR -1589.718%
Eris Lifesciences Limited 38.26 Billion INR 93.438%
Valiant Laboratories Limited 1.05 Billion INR -137.303%
J. B. Chemicals & Pharmaceuticals Limited 10.7 Billion INR 76.548%
Solara Active Pharma Sciences Limited 14.14 Billion INR 82.245%
Ipca Laboratories Limited 33.74 Billion INR 92.558%
Bliss GVS Pharma Limited 2.1 Billion INR -19.083%
Achyut Healthcare Limited 2.01 Million INR -124652.906%
Sun Pharmaceutical Industries Limited 183.56 Billion INR 98.632%
Bajaj HealthCare Limited 4.86 Billion INR 48.409%
RPG Life Sciences Limited 1.38 Billion INR -81.95%
Mankind Pharma Limited 23.87 Billion INR 89.481%
Laurus Labs Limited 42.71 Billion INR 94.121%
Piramal Pharma Limited 74 Billion INR 96.607%
Syncom Formulations (India) Limited 1.16 Billion INR -115.521%
Torrent Pharmaceuticals Limited 82.05 Billion INR 96.939%
Alembic Pharmaceuticals Limited 16.27 Billion INR 84.569%
Glenmark Pharmaceuticals Limited 65.11 Billion INR 96.143%
Unichem Laboratories Limited 8.06 Billion INR 68.878%
Sequent Scientific Limited 8.27 Billion INR 69.65%
Novartis India Limited 1.8 Billion INR -39.43%
Wanbury Limited 3.15 Billion INR 20.416%
Suven Pharmaceuticals Limited 2.03 Billion INR -23.451%
Wockhardt Limited 39.87 Billion INR 93.701%
Themis Medicare Limited 1.88 Billion INR -33.047%
Jagsonpal Pharmaceuticals Limited 296.76 Million INR -746.231%
Jubilant Pharmova Limited 61.27 Billion INR 95.902%
Glenmark Life Sciences Limited 5.18 Billion INR 51.528%
Dr. Reddy's Laboratories Limited 106.96 Billion INR 97.652%
Divi's Laboratories Limited 18.99 Billion INR 86.776%
NATCO Pharma Limited 10.53 Billion INR 76.156%
Gufic Biosciences Limited 5.59 Billion INR 55.154%
IOL Chemicals and Pharmaceuticals Limited 6.32 Billion INR 60.32%
Ind-Swift Limited 13.45 Billion INR 81.333%
Procter & Gamble Health Limited 2.56 Billion INR 1.949%
FDC Limited 3.7 Billion INR 32.296%
Krebs Biochemicals & Industries Limited 2.97 Billion INR 15.557%
Granules India Limited 22.95 Billion INR 89.06%
Medicamen Biotech Limited 940.36 Million INR -167.053%
Alkem Laboratories Limited 48.6 Billion INR 94.833%
AstraZeneca Pharma India Limited 3.66 Billion INR 31.407%
Biofil Chemicals and Pharmaceuticals Limited 288.79 Million INR -769.558%
Brooks Laboratories Limited 248.6 Million INR -910.163%
Megasoft Limited 1.85 Billion INR -35.514%
ZIM Laboratories Limited 2.08 Billion INR -20.69%
Strides Pharma Science Limited 37.68 Billion INR 93.335%
Neuland Laboratories Limited 5.49 Billion INR 54.328%
Morepen Laboratories Limited 4.45 Billion INR 43.691%
Hikal Limited 12.99 Billion INR 80.675%
Indoco Remedies Limited 10.34 Billion INR 75.718%
Aarti Pharmalabs Limited 8.25 Billion INR 69.563%
Kilitch Drugs (India) Limited 643.88 Million INR -290.021%
Mangalam Drugs & Organics Limited 1.97 Billion INR -27.069%
Hester Biosciences Limited 3.59 Billion INR 30.14%